Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma

NCT00521482 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolomide
DRUG: Temozolomide plus Thalidomide

Sponsor

University of Zurich